Some of the biggest names in biotechnology, including Amgen, Moderna, and Sarepta Therapeutics, have pulled out of the upcoming J.P. Morgan Healthcare Conference in San Francisco due to safety and travel concerns related to the Covid-19 pandemic, according to people close to the companies. Additional biopharma companies are weighing whether to do the same.
J.P. Morgan, one of Wall Street’s largest investment banks and the organizer of what is the biggest conference on biotech’s calendar, has insisted that CEOs attend the January event in person, resisting calls to allow for virtual presentations. That has pushed some companies, wary of the close-quarters interactions the meeting is known for, to break with decades of tradition.
Create a display name to comment
This name will appear with your comment